Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
Show episodes
We love to hear from our listeners. Send us a message. Allan Shaw, Chief Financial Officer and Chief Business Officer at Create Medicines, is back on the Business of Biotech this week, with a temperature check on biotech funding and the IPO market. We discuss the implications of recent blockbuster acquisitions, strateg
Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier
We love to hear from our listeners. Send us a message. On this week"s episode of the Business of Biotech, Mardi Dier, CFO at Madrigal Pharmaceuticals, talks about building relationships in investment banking and investor relations before moving into business development and becoming a chief financial officer. Mardi des
We love to hear from our listeners. Send us a message. On this week"s episode of the Business of Biotech, we"re speaking with Bernard Ravina, M.D., CEO at Vima Therapeutics, a company that emerged from stealth in May with $60 million Series A financing to develop an oral candidate for dystonia, a movement disorder. Rav
We love to hear from our listeners. Send us a message. On this week"s episode — the last of our four-part series focused on South Florida — we catch up with Rich Daly, CEO at Catalyst Pharmaceuticals, a member of Life Science Leader"s editorial advisory board and Miami-based location host for our in-person series. Rich
We love to hear from our listeners. Send us a message. On this week"s episode of the Business of Biotech -- part three in a four part series recorded in-person at Catalyst Pharmaceuticals" Miami headquarters -- Anthony Japour, M.D., CEO at iTolerance, talks about his work as a physician treating infectious diseases, hi
We love to hear from our listeners. Send us a message. In this week"s episode of the Business of Biotech -- part two in a four-part series recorded in-person at Catalyst Pharmaceuticals" Miami headquarters -- we"re speaking with Daniel Teper, an entrepreneur and most recently, founder and CEO at NAYA Therapeutics. Base